Ordinary Rebalance | Solactive Healthcare Index | Effective Date 5th April 2024
In the ordinary rebalance, the following composition will be implemented effective open 05.04.2024:
ABBOTT LABORATORIES |
ABBVIE INC |
AGILENT TECHNOLOGIES INC |
ALCON INC |
AMGEN INC |
ASTRAZENECA PLC |
BECTON DICKINSON AND CO |
BIOGEN INC |
BRISTOL-MYERS SQUIBB CO |
CENTENE CORP |
CHUGAI PHARMACEUTICAL CO LTD ORD |
CSL LTD ORD |
DAIICHI SANKYO CO LTD ORD |
DANAHER CORP |
DEXCOM INC |
EDWARDS LIFESCIENCES CORP |
ELEVANCE HEALTH INC |
ELI LILLY & CO |
ESSILORLUXOTTICA |
GE HEALTHCARE TECHNOLOGIES INC |
GILEAD SCIENCES INC |
GSK PLC |
HCA HEALTHCARE INC |
HOYA CORP ORD |
HUMANA INC |
IDEXX LABORATORIES INC |
INTUITIVE SURGICAL INC |
IQVIA HOLDINGS INC |
JOHNSON & JOHNSON |
LONZA GROUP AG |
MEDTRONIC PLC |
MERCK & CO. INC. |
METTLER-TOLEDO INTL |
MODERNA INC |
NOVARTIS AG |
NOVO NORDISK A/S |
PFIZER INC |
REGENERON PHARMACEUTICALS |
RESMED INC |
ROCHE HOLDING AG |
SANOFI SA |
STRYKER CORP |
TAKEDA PHARMACEUTICAL |
THE CIGNA GROUP |
THERMO FISHER SCIENTIFIC INC |
UNITEDHEALTH GROUP INC |
VERTEX PHARMACEUTICALS INC |
WEST PHARMACEUTICAL SERVICES INC |
ZIMMER BIOMET HOLDINGS INC |
ZOETIS INC |